$FLDD
FTAC Emerald Acquisition Corp. Stock $fldd

$fldd Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023086172 Filed on November 13, 2023

Income Statement

Concept	2023 Q3	2022 Q4
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$680.0K	$458.1K
YoY Change	52.54%	356.65%
Operating Profit	-$683.6K
YoY Change	53.34%
Interest Expense	$3.280M	$2.122M
YoY Change	189.5%	400232.08%
% of Operating Profit
Other Income/Expense, Net	-$710.0K
YoY Change
Pretax Income	$1.887M	$1.664M
YoY Change	174.56%	-1767.35%
Income Tax	$680.2K	$462.4K
% Of Pretax Income	36.05%	27.79%
Net Earnings	$1.207M	$1.201M
YoY Change	158.09%	-1303.93%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.04	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$72.75K
YoY Change	-100.0%	-94.08%
Cash & Equivalents	$25.62K	$72.75K
Short-Term Investments
Other Short-Term Assets	$100.0K	$185.2K
YoY Change	-67.78%	-54.98%
Inventory
Prepaid Expenses		$185.2K
Receivables
Other Receivables
Total Short-Term Assets	$109.1K	$258.0K
YoY Change	-84.45%	-84.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$164.0M	$254.3M
YoY Change	-35.03%	14.42%
Other Assets
YoY Change
Total Long-Term Assets	$165.2M	$255.4M
YoY Change	-34.88%	14.26%
TOTAL ASSETS
Total Short-Term Assets	$109.1K	$258.0K
Total Long-Term Assets	$165.2M	$255.4M
Total Assets	$165.3M	$255.7M
YoY Change	-35.01%	13.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$400.0K	$111.1K
YoY Change	229.71%
Accrued Expenses	$1.000M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$1.500M	$21.54K
YoY Change	9018.54%	30.94%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.936M	$492.0K
YoY Change	801.36%	425.75%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.900M	$9.859M
YoY Change	0.41%	11.34%
Total Long-Term Liabilities	$9.900M	$9.859M
YoY Change	0.41%	11.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.936M	$492.0K
Total Long-Term Liabilities	$9.900M	$9.859M
Total Liabilities	$12.80M	$10.35M
YoY Change	25.63%	15.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.54M	-$8.502M
YoY Change	43.12%	42.18%
Common Stock		$98.00
YoY Change		10.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.54M	-$8.501M
YoY Change
Total Liabilities & Shareholders Equity	$165.3M	$255.7M
YoY Change	-35.01%	13.54%

Cashflow Statement

Concept	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	$1.207M	$1.201M
YoY Change	158.09%	-1303.93%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$1.140M	-$629.1K
YoY Change	198.67%	6.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$97.58M	$310.9K
YoY Change	101662.44%	-100.14%
Cash From Investing Activities	$97.58M	$310.9K
YoY Change	101662.44%	-100.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-96.57M	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	-1.140M	-629.1K
Cash From Investing Activities	97.58M	310.9K
Cash From Financing Activities	-96.57M	0.000
Net Change In Cash	-130.0K	-318.2K
YoY Change	-54.51%	-126.45%
FREE CASH FLOW
Cash From Operating Activities	-$1.140M	-$629.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41168
	dei	Entity Registrant Name EntityRegistrantName	FTAC EMERALD ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2170416
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2929 Arch Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1703
	dei	Entity Address City Or Town EntityAddressCityOrTown	Philadelphia
	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19104
	dei	City Area Code CityAreaCode	(215)
	dei	Local Phone Number LocalPhoneNumber	701-9555
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q3	us-gaap	Cash Cash	25623	usd
CY2022Q4	us-gaap	Cash Cash	72753	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	32364	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	185213	usd
CY2023Q3	us-gaap	Prepaid Taxes PrepaidTaxes	51084	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	109071	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	257966	usd
CY2023Q3	emld	Reimbursement Receivable Non Current ReimbursementReceivableNonCurrent	1155000	usd
CY2022Q4	emld	Reimbursement Receivable Non Current ReimbursementReceivableNonCurrent	1155000	usd
CY2023Q3	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	163995984	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	254251750	usd
CY2023Q3	us-gaap	Assets Assets	165260055	usd
CY2022Q4	us-gaap	Assets Assets	255664716	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	447032	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	111063	usd
CY2023Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	967916	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	359410	usd
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	1500000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2936483	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	492008	usd
CY2023Q3	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount	8704270	usd
CY2022Q4	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount	8704270	usd
CY2023Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	12795753	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10351278	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	164001828	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	253814255	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11538485	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8501776	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11537526	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8500817	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	165260055	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	255664716	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	683551	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	445778	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2250994	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1318814	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-683551	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-445778	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2250994	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1318814	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	3278712	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1132965	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9027924	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1497305	usd
CY2023Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-708400	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-708400	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1886761	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	687187	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6068530	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	178491	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	680171	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	219671	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1866506	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	264008	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1206590	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	467516	usd
	us-gaap	Net Income Loss NetIncomeLoss	4202024	usd
	us-gaap	Net Income Loss NetIncomeLoss	-85517	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8500817	usd
CY2023Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2048355	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1267859	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-9281313	usd
CY2023Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2372121	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1727575	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-9925859	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2558741	usd
CY2023Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	967916	usd
CY2023Q3	emld	Contribution For Nonredemption Agreements ContributionForNonredemptionAgreements	-708400	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1206590	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-11537526	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5978418	usd
CY2022Q1	emld	Sale Of Private Placement Units SaleOfPrivatePlacementUnits	860810	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	454360	usd
CY2022Q1	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	2319432	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-464263	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-7446943	usd
CY2022Q2	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	129829	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-88770	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-7665542	usd
CY2022Q3	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	863294	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	467516	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8061320	usd
	us-gaap	Net Income Loss NetIncomeLoss	4202024	usd
	us-gaap	Net Income Loss NetIncomeLoss	-85517	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	9027924	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1497305	usd
	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense	708400	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-152849	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-276341	usd
	emld	Increase Decrease In Prepaid Income Taxes IncreaseDecreaseInPrepaidIncomeTaxes	51084	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	335969	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	44193	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-359410	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	188008	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4039176	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1074280	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	28980354	usd
	emld	Proceedsfrom Cash Withdrawn From Trust Account In Connection With Redemption ProceedsfromCashWithdrawnFromTrustAccountInConnectionWithRedemption	96791644	usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	2492046	usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	237304	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	99283690	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28743050	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	28980362	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1500000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	96791644	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-95291644	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28980362	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-47130	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-836968	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72753	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1227914	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25623	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	390946	usd
	emld	Excise Tax On Stock Redemption ExciseTaxOnStockRedemption	967916	usd
	emld	Deferred Underwriting Payable Charged To Additional Paidin Capital DeferredUnderwritingPayableChargedToAdditionalPaidinCapital	1004270	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	2277000	usd
CY2021Q4	emld	Units Issued During Period Shares New Issues UnitsIssuedDuringPeriodSharesNewIssues	2869342	shares
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	28693420	usd
CY2023Q3	emld	Transaction Costs TransactionCosts	14181568	usd
	emld	Underwriting Commissions UnderwritingCommissions	4973868	usd
	emld	Deferred Underwriting Fees DeferredUnderwritingFees	8704270	usd
	emld	Other Offering Costs OtherOfferingCosts	503430	usd
	emld	Condition For Future Business Combination Use Of Proceeds Percentage ConditionForFutureBusinessCombinationUseOfProceedsPercentage	0.80	pure
	emld	Condition For Future Business Combination Threshold Percentage Ownership ConditionForFutureBusinessCombinationThresholdPercentageOwnership	0.50	pure
	emld	Public Offering Description PublicOfferingDescription	Following the closing of the Public Offering, the partial exercise of the over-allotment option, and the sale of the Private Placement Units, a total of $251,180,354 ($10.10 per Unit) was placed in a Trust Account (“Trust Account”). The proceeds are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except for any interest income released to the Company to pay franchise and income taxes and up to $100,000 of interest to pay dissolution expenses, none of the funds held in trust will be released from the Trust Account until the earlier of (i) the consummation of the initial Business Combination; (ii) the redemption of the public shares if the Company is unable to consummate a Business Combination by January 19, 2024 (the “Completion Window”); or (iii) the redemption of any public shares properly tendered in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company has not consummated the initial Business Combination within the Completion Window, or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public stockholders.
CY2023Q3	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.4762
CY2023Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	96791644	usd
CY2023Q3	us-gaap	Cash Cash	25623	usd
CY2023Q3	emld	Working Capital workingCapital	2827412	usd
CY2021Q4	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	105260	usd
	emld	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	1500000	usd
CY2022	emld	Working Capital Loan Outstanding WorkingCapitalLoanOutstanding	0	usd
	emld	Emerging Growth Company Status EmergingGrowthCompanyStatus	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2023Q3	us-gaap	Cash Cash	25623	usd
CY2022Q4	us-gaap	Cash Cash	72753	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.2621	pure
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.3197	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.2754	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	1.4791	pure
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition.</p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q3	emld	Excise Tax Rate ExciseTaxRate	0.01	pure
CY2022Q3	emld	Fair Market Value Percentages FairMarketValuePercentages	0.01	pure
CY2023Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	9239192	shares
CY2023Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	96791644	usd
CY2023Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	967916	usd
	emld	Excise Tax Liability Percentage ExciseTaxLiabilityPercentage	0.01	pure
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (the “Public Warrants”).
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	248693420	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	8264360	usd
CY2022	emld	Temporary Equity Issuance Cost TemporaryEquityIssuanceCost	-13734146	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	27119341	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	253814255	usd
	us-gaap	Redemption Premium RedemptionPremium	-96791644	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	6979217	usd
CY2023Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	164001828	usd
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On November 12, 2021, the Company effected a 0.9955-for-1.0 stock split, so that the Sponsor owns an aggregate of 8,763,333 Founder Shares.
	emld	Founder Share Percentage FounderSharePercentage	1	pure
	emld	Common Stock Shares Or Exceeds CommonStockSharesOrExceeds	15
CY2021Q4	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	105260	usd
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1500000	usd
CY2023Q1	emld	Related Party Transaction Of Converted Per Shares RelatedPartyTransactionOfConvertedPerShares	10
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	1500000	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	0	usd
CY2023Q1	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1500000	usd
	emld	Working Capital Loans WorkingCapitalLoans	1500000	usd
CY2022	emld	Working Capital Loans WorkingCapitalLoans	0	usd
	emld	Related Party Transaction Expenses From Transactions With Related Party Per Month RelatedPartyTransactionExpensesFromTransactionsWithRelatedPartyPerMonth	30000	usd
	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	180000	usd
	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	21535	usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Current RelatedPartyTaxExpenseDueToAffiliatesCurrent	16451	usd
	emld	Warrant Agreement Description WarrantAgreementDescription	The warrant agreement provides that the terms of the warrants may be amended without the consent of any stockholder or warrant holder to cure any ambiguity or correct any defective provision or to make any amendments that are necessary in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s unaudited condensed financial statements, but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, the Company may amend the terms of the public warrants (i) in a manner adverse to a holder of public warrants if holders of at least 50% of the then outstanding public warrants approve of such amendment or (ii) to the extent necessary for the warrants in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s unaudited condensed financial statements without the consent of any stockholder or warrant holder. Although the Company’s ability to amend the terms of the public warrants with the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or shares, shorten the exercise period or decrease the number of shares of Class A common stock purchasable upon exercise of a warrant.
	us-gaap	Underwriting Expense Ratio UnderwritingExpenseRatio	0.02	pure
	emld	Deferred Underwriting Discount DeferredUnderwritingDiscount	0.035	pure
	emld	Aggregate Percentage Underwritting Expenses AggregatePercentageUnderwrittingExpenses	0.003	pure
	emld	Advisory Fee Percentage advisoryFeePercentage	0.00525	pure
	emld	Deferred Advisory Fee DeferredAdvisoryFee	1155000	usd
	emld	Aggregate Share AggregateShare	1610000	shares
CY2023Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	1610000	usd
	emld	Non Redeeming Shareholders NonRedeemingShareholders	708400	usd
	emld	Non Redeeming Shareholders Par Value NonRedeemingShareholdersParValue	0.44
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	emld	Public Warrant Shares PublicWarrantShares	12434671	shares
CY2022	emld	Private Warrant Shares PrivateWarrantShares	488041	shares
	emld	Description Of Exercise Price And Number Of Shares Of Common Stock DescriptionOfExercisePriceAndNumberOfSharesOfCommonStock	In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
	emld	Sharebased Compensations Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y
	emld	Warrants For Redemption Description WarrantsForRedemptionDescription	Redemption of warrantsOnce the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and ● if, and only if, the last sale price of the Class A common stock (or the closing bid price of the Class A common stock in the event the shares of Class A common stock are not traded on any specific trading day) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.
CY2023Q3	us-gaap	Assets Held In Trust AssetsHeldInTrust	163995984	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	254251750	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes		usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent		usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2022Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
	emld	Nonredemption Agreement Expense NonredemptionAgreementExpense		usd
	emld	Increase Decrease In Prepaid Income Taxes IncreaseDecreaseInPrepaidIncomeTaxes		usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments		usd
	emld	Proceedsfrom Cash Withdrawn From Trust Account In Connection With Redemption ProceedsfromCashWithdrawnFromTrustAccountInConnectionWithRedemption		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	emld	Excise Tax On Stock Redemption ExciseTaxOnStockRedemption		usd
	emld	Deferred Underwriting Payable Charged To Additional Paidin Capital DeferredUnderwritingPayableChargedToAdditionalPaidinCapital		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001889123

Files In Submission

Name	View Source	Status
emld-20230930_cal.xml	Edgar Link	unprocessable
emld-20230930_lab.xml	Edgar Link	unprocessable
0001213900-23-086172-index-headers.html	Edgar Link	pending
0001213900-23-086172-index.html	Edgar Link	pending
0001213900-23-086172.txt	Edgar Link	pending
0001213900-23-086172-xbrl.zip	Edgar Link	pending
emld-20230930.xsd	Edgar Link	pending
f10q0923ex31-1_ftacemerald.htm	Edgar Link	pending
f10q0923ex31-2_ftacemerald.htm	Edgar Link	pending
f10q0923ex32-1_ftacemerald.htm	Edgar Link	pending
f10q0923ex32-2_ftacemerald.htm	Edgar Link	pending
f10q0923_ftacemerald.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
emld-20230930_def.xml	Edgar Link	unprocessable
emld-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_ftacemerald_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FLDD
FTAC Emerald Acquisition Corp. Stock $fldd

2023 Q3 Form 10-Q Financial Statement

#000121390023086172 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLDD FTAC Emerald Acquisition Corp. Stock $fldd

2023 Q3 Form 10-Q Financial Statement

#000121390023086172 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLDD
FTAC Emerald Acquisition Corp. Stock $fldd